Every 10-Q that QUEST PATENT RESEARCH CP (QPRC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow QPRC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full QPRC filings page.
Quest Patent Research Corporation reported its results for the three and six months ended June 30, 2026. The company generated $2,000,000 in patent licensing revenue in Q2 and year-to-date, all from a single lawsuit settlement involving its Koyo portfolio, after having no revenue in the prior-year periods.
Despite this, results remained deeply negative. For the six months, Quest recorded a net loss of $5,053,787 and loss per share of $0.95, driven by $4,058,377 of litigation and licensing expenses and $2,259,060 of selling, general and administrative costs. Operating cash outflows were $3,767,576, partially offset by $4,055,576 of non‑recourse financing draws, increasing cash to $480,606.
The balance sheet shows total assets of $10,009,761 against total liabilities of $32,256,547 and a stockholders’ deficit of $22,246,786, including an accumulated deficit of $39,927,967 and a working capital deficit of about $31.1 million. Large funding liabilities to QPRC Finance and QF3 (together $26,319,092) are payable only from future monetization proceeds. Management states that recurring losses, significant deficits, reliance on litigation outcomes, and limited access to capital raise substantial doubt about the company’s ability to continue as a going concern.
Quest Patent Research Corporation reports a difficult first quarter of 2026, with no revenue and a net loss of $2,936,337, or $0.55 per share. Litigation and licensing expenses rose sharply to $1,710,171, mainly tied to the MR patent portfolio, while selling, general and administrative costs were $1,117,963.
Cash increased to $619,861, but current liabilities reached about $30.2M, including funding liabilities of $24.8M owed to QF3 and QPRC Finance. The company ended the quarter with an accumulated deficit of roughly $37.8M and negative working capital of about $29.6M. Management states these factors raise substantial doubt about its ability to continue as a going concern, given its history of losses, lack of recent revenue, and dependence on successful patent litigation and third-party financing.
Quest Patent Research Corporation reported Q3 2025 results with no revenue and a net loss of $1,230,309 (loss per share $0.23). Selling, general and administrative expenses were $1,011,617 and net other expense was $218,692, including interest expense of $177,787.
For the nine months ended September 30, 2025, the company recorded a net loss of $3,196,485. Cash was $175,141 and current assets totaled $194,432 against current liabilities of $22,706,870, reflecting a negative working capital of about $22,512,000. Management disclosed that these conditions raise substantial doubt about the company’s ability to continue as a going concern.
Total assets rose to $11,012,559 driven by patents of $10,818,127 after MR Licensing purchased a patent portfolio for $9,000,000 funded by QPRC Finance. Funding liabilities were $17,798,856 (QPRC Finance and QF3). Shares outstanding were 5,331,973 as of November 13, 2025.